List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 61 studies with search of:   "Acromegaly"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Glucose Tolerance in Acromegaly: The Influence of GH-Excess on Glucose Metabolism and Insulin Resistance
Conditions: Acromegaly;   Diabetes;   Insulin Resistance;   Impaired Glucose Tolerance
Intervention:
2 Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly;   Pituitary Neoplasm
Intervention:
3 Active, not recruiting Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
Conditions: Carcinoid Tumor;   Acromegaly
Intervention: Drug: Pasireotide
4 Not yet recruiting Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Somatuline Autogel
5 Recruiting Ultrasound Guided Sandostatin LAR Injection in Acromegaly
Condition: Acromegaly
Interventions: Drug: Sandostatin LAR;   Drug: Sandostatin LAR
6 Completed Dose Escalation of Octreotide-LAR as First-Line Therapy in Resistant Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
7 Active, not recruiting An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide
8 Completed Safety and Efficacy of Long-Acting Repeatable Octreotide Acetate for Injectable Suspension Vs. Surgery in Treatment-naïve Patients With Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide LAR – pituitary surgery
9 Completed Impact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide-LAR or lanreotide;   Procedure: Transsphenoidal adenomectomy
10 Recruiting Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly
Condition: Acromegaly
Intervention: Drug: Pasireotide
11 Completed Acute Application of Pegvisomant and Octreotide in Acromegaly
Condition: Acromegaly
Interventions: Drug: pegvisomant;   Drug: combination with somatostatin analogue octreotide;   Drug: combination with dopamine agonist cabergoline
12 Recruiting Somatuline® Depot (Lanreotide) for Acromegaly Post-Marketing Observational Study
Condition: Acromegaly
Intervention:
13 Completed Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
Interventions: Drug: Somatuline Autogel (lanreotide acetate);   Behavioral: Home administration
14 Completed Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Condition: Acromegaly
Intervention: Drug: Lanreotide (Autogel formulation)
15 Recruiting Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant
Conditions: Acromegaly;   Heart Failure;   Hypertrophy, Left Ventricular
Intervention: Drug: pegvisomant
16 Recruiting Physiopathology of Sodium Retention in Acromegaly
Condition: Acromegaly
Intervention: Drug: furosemide
17 Completed Prediction of Tumor Shrinkage in Acromegaly
Condition: Acromegaly
Intervention: Drug: Octreotide-LAR
18 Recruiting Efficacy and Safety Study of Octreotide Implant in Patients With Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide Implant;   Drug: Sandostatin LAR Depot
19 Completed A Study To Compare The Efficacy And Safety Of Pegvisomant To That Of Sandostatin Lar Depot In Patients With Acromegaly
Condition: Acromegaly
Interventions: Drug: Pegvisomant;   Drug: Sandostatin LAR
20 Completed Lanreotide Autogel-120 mg as First-Line Treatment of Acromegaly
Condition: Acromegaly
Intervention: Drug: Lanreotide-Autogel 120 mg

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options